Optimizing selection of large animals for antibody production by screening immune response to standard vaccines
- PMID: 26775851
- PMCID: PMC4769958
- DOI: 10.1016/j.jim.2016.01.006
Optimizing selection of large animals for antibody production by screening immune response to standard vaccines
Abstract
Antibodies made in large animals are integral to many biomedical research endeavors. Domesticated herd animals like goats, sheep, donkeys, horses and camelids all offer distinct advantages in antibody production. However, their cost of use is often prohibitive, especially where poor antigen response is commonplace; choosing a non-responsive animal can set a research program back or even prevent experiments from moving forward entirely. Over the course of production of antibodies from llamas, we found that some animals consistently produced a higher humoral antibody response than others, even to highly divergent antigens, as well as to their standard vaccines. Based on our initial data, we propose that these "high level responders" could be pre-selected by checking antibody titers against common vaccines given to domestic farm animals. Thus, time and money can be saved by reducing the chances of getting poor responding animals and minimizing the use of superfluous animals.
Keywords: Antibody generation; Antigen; Camelid antibody; Immunization; Vaccine.
Copyright © 2016 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.J Virol. 2017 Mar 13;91(7):e02324-16. doi: 10.1128/JVI.02324-16. Print 2017 Apr 1. J Virol. 2017. PMID: 28100620 Free PMC article.
-
Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.Zoonoses Public Health. 2008 Oct;55(8-10):414-20. doi: 10.1111/j.1863-2378.2008.01126.x. Epub 2008 Apr 9. Zoonoses Public Health. 2008. PMID: 18399941
-
Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep.Vaccine. 2011 Feb 1;29(6):1304-10. doi: 10.1016/j.vaccine.2010.11.068. Epub 2010 Dec 4. Vaccine. 2011. PMID: 21134446
-
Practical significance of rabies antibodies in cats and dogs.Rev Sci Tech. 1992 Sep;11(3):735-60. doi: 10.20506/rst.11.3.622. Rev Sci Tech. 1992. PMID: 1472723 Review.
-
Rabies antibody titers in vaccinees: protection, failure and prospects.Int J Clin Pharmacol Ther Toxicol. 1992 Mar;30(3):107-12. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1506120 Review.
Cited by
-
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.bioRxiv [Preprint]. 2021 Apr 10:2021.04.08.438911. doi: 10.1101/2021.04.08.438911. bioRxiv. 2021. Update in: Elife. 2021 Dec 07;10:e73027. doi: 10.7554/eLife.73027 PMID: 33851164 Free PMC article. Updated. Preprint.
-
Host genetic variation explains reduced protection of commercial vaccines against Piscirickettsia salmonis in Atlantic salmon.Sci Rep. 2020 Oct 26;10(1):18252. doi: 10.1038/s41598-020-70847-9. Sci Rep. 2020. PMID: 33106499 Free PMC article.
-
Therapeutic efficacy of SipD/LptD-specific IgY entrapped in alginate nanoparticles against Salmonella Typhimurium infection.Heliyon. 2024 Oct 24;10(21):e39650. doi: 10.1016/j.heliyon.2024.e39650. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39524789 Free PMC article.
-
Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?Front Microbiol. 2021 Apr 15;12:638047. doi: 10.3389/fmicb.2021.638047. eCollection 2021. Front Microbiol. 2021. PMID: 33935997 Free PMC article. Review.
-
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.Elife. 2021 Dec 7;10:e73027. doi: 10.7554/eLife.73027. Elife. 2021. PMID: 34874007 Free PMC article.
References
-
- Appleyard G, Wilkie BN, Kennedy BW, Mallard BA. Antibody avidity in Yorkshire pigs of high and low immune response groups. Vet Immunol Immunopathol. 1992;31:229–40. - PubMed
-
- Coghill RD, Fell N, Creighton M, Brown G. The elimination of horse-serum specificity from antitoxins. J Immunol. 1940;39:207–222.
-
- Eckersley AM, Petrovsky N, Kinne J, Wernery R, Wernery U. Improving the dromedary antibody response: The hunt for the ideal camel adjuvant. J Camel Pract And Res. 2011;18:35–46.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
